Body mass index and fasting insulin predict survival and EGFR–TKI benefit in Stage IV lung adenocarcinoma - Top-Institutions - MDSpire

Body mass index and fasting insulin predict survival and EGFR–TKI benefit in Stage IV lung adenocarcinoma

  • By

  • Huiru Guo

  • Lingshuang Liu

  • Jan P. A. Baak

  • June 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Longhua University Hospital
    Longhua University Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Oncology

  • #2

    Guangdong Provincial People’s Hospital
    Guangdong Provincial People’s Hospital

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology

  • #3

    Guangdong Lung Cancer Institute
    Guangdong Lung Cancer Institute

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology

  • #4

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

  • #5

    Peking University Cancer Hospital
    Peking University Cancer Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

Original Source(s)

Body mass index and fasting insulin predict survival and EGFR–TKI benefit in Stage IV lung adenocarcinoma

  • by Huiru Guo, Lingshuang Liu, Jan P. A. Baak

  • June 25, 2026

Related Content

Necrotizing soft tissue infections: a surgical narrative review

Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study

Intragastric Balloon as a First Step Before Metabolic Bariatric Surgery in Patients with BMI ≥ 50 kg/m2: are the Results After Balloon Related to Global Outcomes After Surgery?